At-home COVID-19 Antigen Tests Preprint and Limited Open-source Data Set Now Available

Published on Wednesday, September 14, 2022

The FDA has published a safety communication regarding At-Home COVID-19 Antigen Tests. In support of this notice, a preprint, Performance of Screening for SARS-CoV-2 using Rapid Antigen Tests to Detect Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infection: findings from the Test Us at Home prospective cohort study and a limited open source data set are now available. The availability of the full study data set, “Rapid Acceleration of Diagnostics - TECH (RADx-TECH): COVID-19 Test At Home Efficacy Sub-Study, phs003026.v1” in the RADx Data Hub is forthcoming.